Comparing Depo-Testosterone vs Testosterone
Depo-Testosterone (testosterone) | Testosterone |
|
---|
Depo-Testosterone (testosterone) | Testosterone |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Hypogonadism - Male, Delayed Puberty - Male, Breast Cancer - Palliative, Postpartum Breast Pain. Depo-Testosterone may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hypogonadism - Male, Gender Affirming Hormone Therapy, Gender Dysphoria, Delayed Puberty - Male, Breast Cancer - Palliative, Postpartum Breast Pain, Klinefelter Syndrome. Testosterone... View more |
Related suggestions Delayed Puberty, Male
Postpartum Breast Pain
|
|||||||||||||||
More about Depo-Testosterone (testosterone) | More about Testosterone | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Depo-Testosterone has an average rating of 9.9 out of 10 from a total of 10 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Testosterone has an average rating of 7.3 out of 10 from a total of 533 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 18% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Depo-Testosterone side effects |
View all Testosterone side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic approved |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Depo-Testosterone prices |
View all Testosterone prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Other testosterone brands include: Andro LA 200, Andro-Cyp 100, Andro-Cyp 200, Androderm, AndroGel, Aveed, Azmiro, Delatest, Depandro 100, Depotest, Duratest, Durathate 200, Everone, FIRST-Testosterone, FIRST-Testosterone MC, Fortesta, Histerone, Jatenzo, Kyzatrex, Natesto, Striant, Testim, Testo-100, Testo-200, Testopel, Testopel Pellets, Testro-LA, Tlando, Undecatrex, Vogelxo, Xyosted View more | Andro LA 200, Andro-Cyp 100, Andro-Cyp 200, Androderm, AndroGel, Aveed, Azmiro, Delatest, Depandro 100, Depo-Testosterone, Depotest, Duratest, Durathate 200, Everone, FIRST-Testosterone, FIRST-Testosterone MC, Fortesta, Histerone, Jatenzo, Kyzatrex, Natesto, Striant, Testim, Testo-100, Testo-200, Testopel, Testopel Pellets, Testro-LA, Tlando, Undecatrex, Vogelxo, Xyosted View more | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
2 hours |
2 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 185 drugs are known to interact with Depo-Testosterone:
|
A total of 185 drugs are known to interact with Testosterone:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
N/A |
December 24, 1953 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.